| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.2M | +8.2% | +1.1% |
| Cost of Revenue | $3.5M | +8.6% | -10.7% |
| Gross Profit | $2.7M | +7.8% | +21.9% |
| R&D Expense | $721K | -6.0% | -27.8% |
| SG&A Expense | $2.0M | +12.6% | +715.8% |
| Operating Income | -$3.1M | +52.2% | +1.1% |
| Pre-tax Income | -$3.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.0M | -61.9% | -81.6% |
| Accounts Receivable | $6.1M | +4.5% | +4.8% |
| Inventory | $7.1M | -6.7% | -2.6% |
| Current Assets | $17.3M | -16.2% | -32.3% |
| Total Assets | $23.2M | -13.5% | -49.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.3M | — | — |
| Capital Expenditures | $5K | — | — |
| Investing Cash Flow | -$5K | — | — |
| Financing Cash Flow | $8.4M | — | — |
| Free Cash Flow | -$13.3M | — | — |
| +51.8% |
| -3.5% |
| Income Tax | $7K | — | -75.9% |
| Net Income | -$3.2M | +51.7% | -2.8% |
| EPS (Basic) | -$0.20 | +65.5% | +42.9% |
| EPS (Diluted) | -$0.20 | +65.5% | +42.9% |
| $9.1M |
| -12.6% |
| -6.3% |
| Total Liabilities | $10.4M | -10.7% | -12.3% |
| Stockholders' Equity | $12.8M | -15.6% | -62.4% |